MENU

KZR Stock Kezar Life Sciences (KZR, $0.77) Moving Average Convergence Divergence (MACD) Histogram turned positive on September 30, 2024

A.I.dvisor
at Tickeron.com
10/01/24
Loading...
KZR - Kezar Life Sciences
MACD signal
Bullish Trend
Odds of UP Trend
Tickeron
MACD signal
Price: $0.7732
Daily change: +$0.2293 (+42.16%)
Daily volume: 16.1M
Capitalization: $56.4M
Industry: Biotechnology
This is a Bullish indicator signaling KZR's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 44 similar cases where KZR's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

KZR in upward trend: 10-day moving average moved above 50-day moving average on October 02, 2024

The 10-day moving average for KZR crossed bullishly above the 50-day moving average on October 02, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 18, 2024. You may want to consider a long position or call options on KZR as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for KZR just turned positive on September 30, 2024. Looking at past instances where KZR's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

KZR moved above its 50-day moving average on September 30, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KZR advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for KZR moved out of overbought territory on October 17, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 52 cases where KZR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KZR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

KZR broke above its upper Bollinger Band on September 30, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for KZR entered a downward trend on September 27, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.374) is normal, around the industry mean (12.594). P/E Ratio (0.000) is within average values for comparable stocks, (111.595). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.971). KZR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (8.039) is also within normal values, averaging (224.025).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KZR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KZR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
KZR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapies targeting protein homeostasis

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4000 Shoreline Court
Phone
+1 650 822-5600
Employees
58
Web
https://www.kezarlifesciences.com